9th Aug 2011 07:00
For immediate release | 9 August 2011 |
Alliance Pharma plc
TR-1: Notification of major interest in shares
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: | Alliance Pharma plc | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | Yes | |||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | n/a | |||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | n/a | |||
An event changing the breakdown of voting rights | n/a | |||
Other (please specify): | On market transfer between direct and indirect funds | n/a | ||
3. Full name of person(s) subject to thenotification obligation: | Royal Bank of Canada | |||
4. Full name of shareholder(s) (if different from 3.): | Roy Nominees Limited | |||
5. Date of the transaction and date onwhich the threshold is crossed orreached: | 03 August 2011 | |||
6. Date on which issuer notified: | 05 August 2011 | |||
7. Threshold(s) that is/are crossed orreached: | 10%
| |||
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares | ||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights | ||||||||||||
Direct | Direct | Indirect | Direct | Indirect | ||||||||||||
Ordinary GBP 0.01 shares ISIN GB0031030819 | 23,001,088 | 23,001,088 | 24,001,088 | 24,001,088 | 10% | |||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Expirationdate | Exercise/Conversion Period | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | ||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date | Exercise/Conversion period | Number of voting rights instrument refers to
| % of voting rights
| |||||||||||
| Nominal | Delta | ||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
24,001,088 | 10% | |||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: | ||
The shares are held in the name Roy Nominees Limited for the benefit of trusts administered by RBC Trustees (CI) Limited and RBC cees Trustee Limited which are wholly owned by its ultimate parent, Royal Bank of Canada. | ||
Proxy Voting: | ||
10. Name of the proxy holder: | ||
11. Number of voting rights proxy holder will ceaseto hold: | ||
12. Date on which proxy holder will cease to holdvoting rights: | ||
13. Additional information: | ||
14. Contact name: | Scott Roberts
| |
15. Contact telephone number: |
01534 602971 | |
Related Shares:
Alliance Pharma